FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309887002> ?p ?o ?g. }

• W4309887002 endingPage "e005132" @default.
• W4309887002 startingPage "e005132" @default.
• W4309887002 abstract "Background Nivolumab is an anti-PD-1 antibody approved for treating metastatic melanoma (MM), for which still limited evidence is available on the correlation between drug exposure and patient outcomes. Methods In this observational retrospective study, we assessed whether nivolumab concentration is associated with treatment response in 88 patients with MM and if the patient’s genetic profile plays a role in this association. Results We observed a statistically significant correlation between nivolumab serum concentration and clinical outcomes, measured as overall and progression-free survival. Moreover, patients who achieved a clinical or partial response tended to have higher levels of nivolumab than those who reached stable disease or had disease progression. However, the difference was not statistically significant. In particular, patients who reached a clinical response had a significantly higher concentration of nivolumab and presented a distinct genetic signature, with more marked activation of ICOS and other genes involved in effector T-cells mediated proinflammatory pathways. Conclusions In conclusion, these preliminary results show that in patients with MM, nivolumab concentration correlates with clinical outcomes and is associated with an increased expression of ICOS and other genes involved in the activation of T effectors cells." @default.
• W4309887002 created "2022-11-29" @default.
• W4309887002 creator A5007787317 @default.
• W4309887002 creator A5008736570 @default.
• W4309887002 creator A5010799295 @default.
• W4309887002 creator A5011521807 @default.
• W4309887002 creator A5017778536 @default.
• W4309887002 creator A5018218825 @default.
• W4309887002 creator A5019522534 @default.
• W4309887002 creator A5021193894 @default.
• W4309887002 creator A5024849948 @default.
• W4309887002 creator A5027289800 @default.
• W4309887002 creator A5032306397 @default.
• W4309887002 creator A5035668331 @default.
• W4309887002 creator A5035710316 @default.
• W4309887002 creator A5036337907 @default.
• W4309887002 creator A5048209523 @default.
• W4309887002 creator A5050938952 @default.
• W4309887002 creator A5056211996 @default.
• W4309887002 creator A5059698006 @default.
• W4309887002 creator A5073308643 @default.
• W4309887002 creator A5074642384 @default.
• W4309887002 creator A5081655818 @default.
• W4309887002 creator A5083659627 @default.
• W4309887002 creator A5086743021 @default.
• W4309887002 date "2022-11-01" @default.
• W4309887002 modified "2023-10-05" @default.
• W4309887002 title "Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis" @default.
• W4309887002 cites W1990434045 @default.
• W4309887002 cites W2118503880 @default.
• W4309887002 cites W2160834915 @default.
• W4309887002 cites W2183144139 @default.
• W4309887002 cites W2560367415 @default.
• W4309887002 cites W2565164803 @default.
• W4309887002 cites W2567068937 @default.
• W4309887002 cites W2726861941 @default.
• W4309887002 cites W2752227448 @default.
• W4309887002 cites W2900730698 @default.
• W4309887002 cites W2901472822 @default.
• W4309887002 cites W2919428266 @default.
• W4309887002 cites W2967217932 @default.
• W4309887002 cites W3003803477 @default.
• W4309887002 cites W3011603183 @default.
• W4309887002 cites W3023417503 @default.
• W4309887002 cites W3041045772 @default.
• W4309887002 cites W3087697977 @default.
• W4309887002 cites W3154275034 @default.
• W4309887002 cites W4241519036 @default.
• W4309887002 doi "https://doi.org/10.1136/jitc-2022-005132" @default.
• W4309887002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36424033" @default.
• W4309887002 hasPublicationYear "2022" @default.
• W4309887002 type Work @default.
• W4309887002 citedByCount "0" @default.
• W4309887002 crossrefType "journal-article" @default.
• W4309887002 hasAuthorship W4309887002A5007787317 @default.
• W4309887002 hasAuthorship W4309887002A5008736570 @default.
• W4309887002 hasAuthorship W4309887002A5010799295 @default.
• W4309887002 hasAuthorship W4309887002A5011521807 @default.
• W4309887002 hasAuthorship W4309887002A5017778536 @default.
• W4309887002 hasAuthorship W4309887002A5018218825 @default.
• W4309887002 hasAuthorship W4309887002A5019522534 @default.
• W4309887002 hasAuthorship W4309887002A5021193894 @default.
• W4309887002 hasAuthorship W4309887002A5024849948 @default.
• W4309887002 hasAuthorship W4309887002A5027289800 @default.
• W4309887002 hasAuthorship W4309887002A5032306397 @default.
• W4309887002 hasAuthorship W4309887002A5035668331 @default.
• W4309887002 hasAuthorship W4309887002A5035710316 @default.
• W4309887002 hasAuthorship W4309887002A5036337907 @default.
• W4309887002 hasAuthorship W4309887002A5048209523 @default.
• W4309887002 hasAuthorship W4309887002A5050938952 @default.
• W4309887002 hasAuthorship W4309887002A5056211996 @default.
• W4309887002 hasAuthorship W4309887002A5059698006 @default.
• W4309887002 hasAuthorship W4309887002A5073308643 @default.
• W4309887002 hasAuthorship W4309887002A5074642384 @default.
• W4309887002 hasAuthorship W4309887002A5081655818 @default.
• W4309887002 hasAuthorship W4309887002A5083659627 @default.
• W4309887002 hasAuthorship W4309887002A5086743021 @default.
• W4309887002 hasBestOaLocation W43098870021 @default.
• W4309887002 hasConcept C117220453 @default.
• W4309887002 hasConcept C121608353 @default.
• W4309887002 hasConcept C126322002 @default.
• W4309887002 hasConcept C143998085 @default.
• W4309887002 hasConcept C167135981 @default.
• W4309887002 hasConcept C203014093 @default.
• W4309887002 hasConcept C2524010 @default.
• W4309887002 hasConcept C2777658100 @default.
• W4309887002 hasConcept C2777701055 @default.
• W4309887002 hasConcept C2779134260 @default.
• W4309887002 hasConcept C2780030458 @default.
• W4309887002 hasConcept C2994587330 @default.
• W4309887002 hasConcept C33923547 @default.
• W4309887002 hasConcept C502942594 @default.
• W4309887002 hasConcept C51785407 @default.
• W4309887002 hasConcept C71924100 @default.
• W4309887002 hasConcept C8891405 @default.
• W4309887002 hasConceptScore W4309887002C117220453 @default.
• W4309887002 hasConceptScore W4309887002C121608353 @default.
• W4309887002 hasConceptScore W4309887002C126322002 @default.

• next